Swisher appoints Neil Kiely as CEO and Jeffrey Brown as VP of Sales

Dec.06.2022
Swisher appoints Neil Kiely as CEO and Jeffrey Brown as VP of Sales
Swisher, a well-known US cigarette company, appoints Neil Kiely as CEO and Jeffrey Brown as VP of Sales.

The well-known American cigarette company Swisher has appointed Neil Kiely as President and CEO, and Jeffrey Brown as Executive VP of Sales. Kiely previously served as President of Swisher, while Brown was the General Manager of Swisher's sister company, E-Alternative Solutions (EAS).


As the President and CEO, Kelly will lead Swisher Company's strategic growth, transformation, and diversification in their investment portfolio. She brings over 30 years of experience in developing and transforming consumer packaged goods (CPG) companies.


The first action taken by Keely as President and CEO was to hire Brown to lead the sales team at Swisher. Brown has over 37 years of industry and leadership experience in multiple CPG categories including cigars, e-cigarettes, and CBD. At EAS, Brown was responsible for staffing the team and developing and implementing strategic plans for new products.


Since joining EAS in 2014, Brown has made significant progress and demonstrated leadership abilities and acumen required to manage Swisher's global sales strategy," said Keely. "With experience in leading large sales teams and innovatively launching new products, Brown has earned this opportunity and has the capability to lead us in continuing to transform and diversify our product portfolio.


The appointments of Kiley and Brown were made following the recent appointment of Chris Howard as Executive Vice President in charge of external affairs and new product compliance. Kiley, Brown, and Howard are members of the company's executive leadership team, which also includes Jacinta Carter, Executive Vice President of HR, Personnel, and Culture; Christopher Casey, Executive Vice President and General Counsel; and Edward Barlow, Senior Vice President of Operations.


2FIRSTS will continue to track and report on this issue. Further updates will be available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
Ireland’s 2026 amendment bill to regulate nicotine pouches and tighten rules on vaping products
The Irish government has approved the publication of the Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026. The bill would ban the sale of nicotine consumption products such as nicotine pouches to those under 18 and further regulate nicotine vaping products.
Mar.05 by 2FIRSTS.ai
Over 160 organizations urge Formula 1 to end all tobacco sponsorships, including nicotine pouches
Over 160 organizations urge Formula 1 to end all tobacco sponsorships, including nicotine pouches
On March 4, 2026, more than 160 public interest organizations worldwide sent a letter to Formula 1 urging it to expand its 2006 prohibition on cigarette sponsorships to include nicotine pouches and other tobacco products. The letter states that Philip Morris International sponsors Ferrari to promote ZYN pouches, while British American Tobacco sponsors McLaren with its Velo brand, with logos displayed on cars and drivers’ race suits and promoted on social media.
Mar.06 by 2FIRSTS.ai
Imperial Brands Launches Red, Gold and Silver iD Heated Tobacco Sticks in Europe
Imperial Brands Launches Red, Gold and Silver iD Heated Tobacco Sticks in Europe
Imperial Brands PLC said on February 18, 2026 that it has launched its new Red, Gold and Silver iD heated tobacco sticks in Greece and Poland, with a broader rollout across Europe planned for 2026.
Feb.18
Australian police seize tobacco and vape products in roadside stop: goods valued at A$784,950
Australian police seize tobacco and vape products in roadside stop: goods valued at A$784,950
Australian police say that during a roadside inspection in southern New South Wales, they seized 293,200 cigarettes, 265kg of hard-pressed tobacco leaf and 2,290 vape products from a van bearing Victorian number plates, with an estimated street value of A$784,950.
Feb.26 by 2FIRSTS.ai
ACT Health Minister Vows Continued Crackdown on E-Cigarettes and Illicit Tobacco
ACT Health Minister Vows Continued Crackdown on E-Cigarettes and Illicit Tobacco
ACT Health Minister Rachel Stephen-Smith said the government would not ease its action against e-cigarettes and illicit tobacco and would continue strengthening regulation, legislation, and enforcement. Speaking at the launch of a new program to help young people quit vaping, she said reducing tobacco excise would not materially reduce profits in the illicit tobacco market.
Mar.10 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02